Demonstration and characterization of antibody in tears following intranasal vaccination with inactivated type 13 rhinovirus: a preliminary report.
D000328:Adult; D000917:Antibody Formation; D002499:Centrifugation, Density Gradient; D046508:Culture Techniques; D005128:Eye Diseases / Q000276:immunology; D006801:Humans; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis*; D007136:Immunoglobulins / Q000032:analysis; D008297:Male; D009113:Muramidase / Q000032:analysis; D009500:Neutralization Tests; D009666:Nose; D012229:Rhinovirus / Q000276:immunology*; D013666:Tears / Q000276:immunology*; D013997:Time Factors; D014612:Vaccines / Q000008:administration & dosage
D007074:Immunoglobulin G; D007136:Immunoglobulins; D014612:Vaccines; D009113:Muramidase